Episode Details

In March 2026, the corporate world watched as Finch Therapeutics, a company that once promised to turn human waste into a billion-dollar FDA-approved drug, spectacularly imploded. This episode takes you deep into the forensic audit of Finch's downfall, a chilling narrative of ambition, regulation, and biological entropy. Our hosts, the cynical, street-level Marcus and the clinically detached Katie, dissect the "Ostrich Algorithm" that led to Finch burying its head in data while its pipes burst. From the initial public offering of $960 million to a fire sale at $16.9 million, they explore how "bottling a living swamp" became "panning for gold in a backed-up sewer," ultimately drowning the company in its own mud. The collapse wasn't a market correction; it was a "biblical flood." Katie meticulously outlines the cold, hard metrics: a 95% workforce reduction, the termination of the Takeda collaboration, and a staggering 203.87% Debt-to-Equity ratio. But Marcus cuts through the jargon, revealing the "insurmountable wall" of FDA SARS-CoV-2 donor screening protocols that rendered Finch's raw material too expensive to harvest. What was touted as a "Human-First Discovery platform" became a "cactus strategy," a "banana stand on bespoke artisanal effluent" that forgot the health code violations. The common people, who bought into the dream of a "healthy gut microbiome," are left staring at a $14.17 million net loss, their gut bleeding out while the architects move on. As the audit progresses, the tension between Marcus and Katie builds, hinting at a shared, unresolved past. He probes the personal cost of her "cold compliance," reminding her of a red binder clutched in the Roppongi rain, while she dismisses his "salacious conjecture." In the end, raw biology loses to the sterile, synthetic spore, as competitors like Seres and Vedanta find a way to abstract the messiness of life. Finch becomes a "zombie giant," then a "cadaver being meticulously disassembled." The rot, once smelled by Cassandra, spreads to the core logic of the system itself. This isn't just a financial collapse; it's a profound systemic failure, a "standardization of decay" where the market demands efficiency, not sentiment, and the final tally is nothing but dust.